Profile data is unavailable for this security.
About the company
Coegin Pharma AB, formerly GoldBlue AB (publ) is a Sweden-based biotechnology company. The Company focuses on the development of small molecule therapies aimed at the key enzyme, which is known for its involvement in a variety of inflammatory diseases as well as in cancer. Coegin Pharma AB provides consulting and management services in drug development as well.
- Revenue in SEK (TTM)0.00
- Net income in SEK-27.98m
- Incorporated2016
- Employees--
- LocationCoegin Pharma ABc/o Medicon VillageLUND 223 81SwedenSWE
- Phone+46 855925266
- Websitehttps://coeginpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Modus Therapeutics Holding AB | 0.00 | -17.90m | 36.84m | 2.00 | -- | 2.08 | -- | -- | -1.04 | -1.04 | 0.00 | 0.492 | 0.00 | -- | -- | 0.00 | -114.31 | -141.06 | -237.09 | -278.44 | -- | -- | -- | -- | -- | -10.96 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
Elicera Therapeutics AB | 11.23m | -16.40m | 41.23m | 2.00 | -- | 1.42 | -- | 3.67 | -0.8289 | -0.8289 | 0.5677 | 0.8291 | 0.2937 | -- | 8.15 | 5,615,030.00 | -42.88 | -40.06 | -66.66 | -49.74 | -- | -- | -146.02 | -415.41 | -- | -- | -- | -- | 777.23 | -- | 15.64 | -- | -- | -- |
Veg of Lund AB (publ) | 4.82m | -19.91m | 43.53m | 7.00 | -- | 1.04 | -- | 9.04 | -0.7328 | -0.7328 | 0.1519 | 1.01 | 0.1337 | 13.74 | 14.40 | 688,000.00 | -55.27 | -129.03 | -82.56 | -209.20 | -384.61 | -781.09 | -413.50 | -923.73 | 0.1256 | -12.90 | 0.1405 | -- | 89.57 | 39.87 | 56.02 | -- | -12.47 | -- |
Oncozenge AB | 0.00 | -15.90m | 50.19m | -- | -- | 2.69 | -- | -- | -1.36 | -1.36 | 0.00 | 1.59 | 0.00 | -- | -- | -- | -55.57 | -- | -60.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 65.91 | -- | -- | -- |
ViroGates A/S | 8.71m | -18.87m | 55.11m | 10.00 | -- | 2.08 | -- | 6.33 | -6.12 | -6.12 | 1.61 | 2.64 | 0.2653 | 0.2654 | 3.15 | 558,300.00 | -57.47 | -46.58 | -63.01 | -52.09 | 78.83 | 77.91 | -216.66 | -238.01 | 8.56 | -23.89 | 0.2376 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
Coegin Pharma AB | 0.00 | -27.98m | 57.37m | -- | -- | 4.40 | -- | -- | -2.67 | -2.67 | 0.00 | 0.6404 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -- | -- | -170.65 | -- | -- | -- | -- | 20.60 | -- | -- | -- |
Diagonal Bio AB | 23.00k | -11.68m | 59.06m | 4.00 | -- | 0.2698 | -- | 2,567.66 | -0.1982 | -0.1982 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 5,750.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -104.20 | -- | -- | -88.67 | -- | 27.75 | -- | -- | -- |
Orphazyme A/S | 0.00 | -40.63m | 60.58m | 1.00 | -- | 2.73 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
Chosa Oncology AB | 73.00k | -23.94m | 60.85m | -- | -- | 3.50 | -- | 833.59 | -0.3524 | -0.3524 | 0.0013 | 0.2684 | 0.003 | -- | 0.013 | -- | -96.68 | -51.96 | -178.66 | -61.92 | -- | -- | -32,798.63 | -708.47 | -- | -97.97 | -- | -- | -98.21 | -- | 28.33 | -- | -- | -- |
PCI Biotech Holding ASA | 2.96m | -20.14m | 61.06m | 7.00 | -- | 1.58 | -- | 20.60 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | -- | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
Double Bond Phrmcutcl Intrntnl AB (publ) | 1.37m | -17.34m | 62.44m | 10.00 | -- | 11.12 | -- | 45.56 | -0.1837 | -0.1837 | 0.0136 | 0.0556 | 0.1016 | -- | 18.59 | 137,033.00 | -128.49 | -80.90 | -198.98 | -106.45 | -241.22 | -686.41 | -1,265.24 | -1,360.03 | -- | -217.55 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
Pila Pharma AB | 1.46m | -9.93m | 62.81m | 1.00 | -- | 9.43 | -- | 42.93 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
Abera Bioscience AB | 0.00 | -16.72m | 74.46m | -- | -- | 12.40 | -- | -- | -1.24 | -1.24 | 0.00 | 0.391 | 0.00 | -- | -- | -- | -115.63 | -79.43 | -149.06 | -96.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.73 | -- | -- | -- |
Spago Nanomedical AB (publ) | 1.20m | -42.22m | 75.28m | 13.00 | -- | 1.78 | -- | 62.58 | -0.3818 | -0.3818 | 0.0115 | 0.1882 | 0.0093 | -- | 5.74 | 92,538.46 | -32.61 | -20.19 | -35.38 | -20.97 | 247.55 | -- | -3,509.81 | -4,853.45 | -- | -- | -- | -- | 14.14 | -- | -7.72 | -- | -- | -- |
Combigene AB | 5.54m | -35.67m | 76.23m | 11.00 | -- | 0.6546 | -- | 13.75 | -1.80 | -1.80 | 0.28 | 5.88 | 0.0398 | -- | 2.63 | 504,000.00 | -25.58 | -13.00 | -26.56 | -14.58 | -- | -- | -643.33 | -58.77 | -- | -- | -- | -- | -79.24 | 268.58 | -479.27 | -- | -- | -- |
Alzinova AB | 270.00k | -16.48m | 77.93m | -- | -- | 0.6845 | -- | 288.63 | -0.4149 | -0.4149 | 0.0067 | 2.56 | 0.0023 | -- | 0.3671 | -- | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.55 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
Data as of Apr 19 2024. Currency figures normalised to Coegin Pharma AB's reporting currency: Swedish Krona SEK